Literature DB >> 19003411

Recombinant insulin-like growth factor-I (IGF-I) production in Super-CHO results in the expression of IGF-I receptor and IGF binding protein 3.

N A Sunstrom1, M Baig, L Cheng, D Payet Sugyiono, P Gray.   

Abstract

Previously, we described the genetic construction Super- CHO, a cell line capable of autocrine growth under fully defined protein-free conditions. Super-CHO cells constitutively express insulin growth factor-I (IGF-I) and transferrin in sufficient amounts to support long-term, stable growth without the addition of exogenous growth factors, thus making it an ideal host for the production of recombinant biopharmaceuticals. although IGF-I has been successfully expressed in Chinese Hamster Ovary (CHO) cells, the long term effects of recombinant IGF-I expression have not been explored. In particular, the expression of the endogenous IGF-I receptor in response to IGF-I production has not been reported. We report here the transcriptional induction of the type I IGF receptor gene in Super-CHO. In addition, we examined the conditioned medium for the presence of IGF-I binding proteins. Ligand blot analysis reveals the presence of IGF binding proteins present in the medium conditioned by Super-CHO cells as well as CHO cells incubated in the presence of IGF-I. Furthermore, immunoaffinity reveals that Super-CHO expresses IGF binding protein-3 in response to IGF-I production. These results suggest the autocrine growth of Super-CHO involves a complex interaction of cell type specific factors which regulate its utility of IGF-I.

Entities:  

Year:  1998        PMID: 19003411      PMCID: PMC3449832          DOI: 10.1023/A:1008073513948

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  36 in total

Review 1.  The somatomedins: insulin-like growth factors.

Authors:  R C Baxter
Journal:  Adv Clin Chem       Date:  1986       Impact factor: 5.394

Review 2.  Molecular and cellular aspects of the insulin-like growth factor I receptor.

Authors:  D LeRoith; H Werner; D Beitner-Johnson; C T Roberts
Journal:  Endocr Rev       Date:  1995-04       Impact factor: 19.871

3.  High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum.

Authors:  R C Baxter; J L Martin; V A Beniac
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

4.  Expression and characterization of a functional human insulin-like growth factor I receptor.

Authors:  G Steele-Perkins; J Turner; J C Edman; J Hari; S B Pierce; C Stover; W J Rutter; R A Roth
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

5.  Paradoxical biological effects of overexpressed insulin-like growth factor-1 receptors in Chinese hamster ovary cells.

Authors:  H Kato; T N Faria; B Stannard; R Levy-Toledano; S I Taylor; C T Roberts; D LeRoith
Journal:  J Cell Physiol       Date:  1993-07       Impact factor: 6.384

6.  Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream.

Authors:  C Lalou; M Binoux
Journal:  Regul Pept       Date:  1993-10-20

7.  Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts.

Authors:  R S Birnbaum; K M Wiren
Journal:  Endocrinology       Date:  1994-07       Impact factor: 4.736

8.  Insulin-like growth factor-II (IGF-II), type 2 IGF receptor, and IGF-binding protein-2 gene expression in rat lung alveolar epithelial cells: relation to proliferation.

Authors:  O B Mouhieddine; V Cazals; B Maitre; Y Le Bouc; K Chadelat; A Clement
Journal:  Endocrinology       Date:  1994-07       Impact factor: 4.736

9.  A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.

Authors:  C Y Lee; M M Rechler
Journal:  Endocrinology       Date:  1995-02       Impact factor: 4.736

10.  Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.

Authors:  P Cohen; D M Peehl; B Baker; F Liu; R L Hintz; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958

View more
  4 in total

1.  Effects of clonal variation on growth, metabolism, and productivity in response to trophic factor stimulation: a study of Chinese hamster ovary cells producing a recombinant monoclonal antibody.

Authors:  Hussain Dahodwala; Mark Nowey; Tatyana Mitina; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2011-08-06       Impact factor: 2.058

2.  Tyrosine Phosphorylation of the Myosin Regulatory Light Chain Controls Non-muscle Myosin II Assembly and Function in Migrating Cells.

Authors:  Rocío Aguilar-Cuenca; Clara Llorente-González; Jessica R Chapman; Vanessa C Talayero; Marina Garrido-Casado; Cristina Delgado-Arévalo; María Millán-Salanova; Jeffrey Shabanowitz; Donald F Hunt; James R Sellers; Sarah M Heissler; Miguel Vicente-Manzanares
Journal:  Curr Biol       Date:  2020-06-04       Impact factor: 10.834

3.  Regulated autocrine growth of CHO cells.

Authors:  N A Sunstrom; S Hunt; C Bailey; M Baig; M Sleigh; P Gray
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

4.  Glucose lowering effect of transgenic human insulin-like growth factor-I from rice: in vitro and in vivo studies.

Authors:  Stanley Ck Cheung; Li-Zhong Liu; Lin-Lin Lan; Qiao-Quan Liu; Samuel Sm Sun; Juliana Cn Chan; Peter Cy Tong
Journal:  BMC Biotechnol       Date:  2011-04-12       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.